Department of Pharmacology, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan; Center for Innovative and Translational Medicine, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan.
Department of Pharmacology, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan.
Biochem Biophys Res Commun. 2021 Apr 9;548:84-90. doi: 10.1016/j.bbrc.2021.02.051. Epub 2021 Feb 23.
Brain nicotinic acetylcholine receptors (nAChRs) reportedly suppress the micturition, but the mechanisms responsible for this suppression remain unclear. We previously reported that intracerebroventricularly administered (±)-epibatidine (non-selective nAChR agonist) activated the sympatho-adrenomedullary system, which can affect the micturition. Therefore, we investigated (1) whether intracerebroventricularly administered (±)-epibatidine-induced effects on the micturition were dependent on the sympatho-adrenomedullary system, and (2) brain nAChR subtypes involved in the (±)-epibatidine-induced effects in urethane-anesthetized male Wistar rats. Plasma noradrenaline and adrenaline (catecholamines) were measured just before and 5 min after (±)-epibatidine administration. Evaluation of urodynamic parameters, intercontraction intervals (ICI) and maximal voiding pressure (MVP) by cystometry was started 1 h before (±)-epibatidine administration or intracerebroventricular pretreatment with other drugs and continued 1 h after (±)-epibatidine administration. Intracerebroventricularly administered (±)-epibatidine elevated plasma catecholamines and prolonged ICI without affecting MVP, and these changes were suppressed by intracerebroventricularly pretreated mecamylamine (non-selective nAChR antagonist). Acute bilateral adrenalectomy abolished the (±)-epibatidine-induced elevation of plasma catecholamines, but had no effect on the (±)-epibatidine-induced ICI prolongation. The latter was suppressed by intracerebroventricularly pretreated methyllycaconitine (selective α7-nAChR antagonist), SR95531 (GABA antagonist), and SCH50911 (GABA antagonist), but not by dihydro-β-erythroidine (selective α4β2-nAChR antagonist). Intracerebroventricularly administered PHA568487 (selective α7-nAChR agonist) prolonged ICI without affecting MVP, similar to (±)-epibatidine. These results suggest that stimulation of brain α7-nAChRs suppresses the rat micturition through brain GABA/GABA receptors, independently of the sympatho-adrenomedullary outflow modulation.
脑烟碱型乙酰胆碱受体(nAChRs)据报道可抑制排尿,但负责这种抑制的机制仍不清楚。我们之前报道过,脑室内给予(±)-epibatidine(非选择性 nAChR 激动剂)可激活交感-肾上腺髓质系统,这可能会影响排尿。因此,我们研究了(1)脑室内给予(±)-epibatidine 对排尿的影响是否依赖于交感-肾上腺髓质系统,以及(2)脑内 nAChR 亚型在乌拉坦麻醉雄性 Wistar 大鼠中(±)-epibatidine 诱导作用中的作用。在(±)-epibatidine 给药前后测量血浆去甲肾上腺素和肾上腺素(儿茶酚胺)。在(±)-epibatidine 给药前 1 小时开始通过膀胱测压法评估尿动力学参数、收缩间期(ICI)和最大排空压(MVP),并在(±)-epibatidine 给药后 1 小时继续进行。脑室内给予(±)-epibatidine 可升高血浆儿茶酚胺并延长 ICI,而不影响 MVP,这些变化可被脑室内预先给予的美加明(非选择性 nAChR 拮抗剂)抑制。急性双侧肾上腺切除术消除了(±)-epibatidine 引起的血浆儿茶酚胺升高,但对(±)-epibatidine 引起的 ICI 延长没有影响。后者可被脑室内预先给予的甲基lycaconitine(选择性α7-nAChR 拮抗剂)、SR95531(GABA 拮抗剂)和 SCH50911(GABA 拮抗剂)抑制,但不能被二氢-β-erythroidine(选择性α4β2-nAChR 拮抗剂)抑制。脑室内给予 PHA568487(选择性α7-nAChR 激动剂)可延长 ICI,而不影响 MVP,类似于(±)-epibatidine。这些结果表明,脑内α7-nAChR 的刺激通过脑内 GABA/GABA 受体抑制大鼠排尿,而不依赖于交感-肾上腺髓质传出调制。